Effects of Arthritis Drugs and Steroids Drugs to Save COVID-19 Patients' Life

Department

Infectious Diseases

Document Type

Article

Publication Title

Journal of Population Therapeutics and Clinical Pharmacology

Abstract

Introduction: The World Health Organization (WHO) announced the coronavirus disease 2019 (COVID-19) occurrence as a global pandemic in March 2020.

Objectives: The basic aim of the study is to find the effects of arthritis drugs and steroids drugs to save COVID-19 patients’ life.

Material and methods: This retrospective cohort study was conducted in Lady Reading Hospital, Peshawar from October 2022 to march 2023. Ethical approval was obtained from the institutional review board (IRB) before the commencement of data collection.The study included a total of 420 COVID-19 patients who met the inclusion criteria and were divided into four groups based on the treatments they received: arthritis drugs (Group A), steroid medications (Group B), combination therapy with both arthritis drugs and steroids (Group C), and standard care (Group D).

Results: Data was collected from 420 patients suffering from COVID-19. The mean age of the study population was 52.5±8.2 years. 56% of the participants were male, and 44% were female. Common comorbidities among the patients included hypertension (32%), diabetes (24%), and cardiovascular disease (18%), with 82% of patients having at least one comorbidity.

Conclusion: It is concluded that steroids, commonly used for arthritis, may improve outcomes in COVID-19 patients with comorbidities. Individualized treatment decisions considering benefits and risks are crucial in COVID-19 management.

First Page

170

Last Page

175

DOI

10.53555/jptcp.v30i18.3050

Volume

30

Issue

18

Publication Date

10-2023

Link to Full Text

Share

COinS